SCHEMBL2763422

SCHEMBL2763422

Nc1nc(-c2ccc(Cl)s2)cs1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.63
MAPT P10636 8/20 0.63
HSD17B10 Q99714 7/20 0.63
NPC1 O15118 6/20 0.63
GFER P55789 1/20 0.63
CYP3A4 P08684 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
KDM4E B2RXH2 5/20 0.50
RAB9A P51151 5/20 0.50
LMNA P02545 4/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
HTT P42858 3/20 0.47
NPSR1 Q6W5P4 1/20 0.47
LTA4H P09960 2/20 0.46
TSHR P16473 3/20 0.46
MAPK1 P28482 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17221556 0.78 ALDH1A1 (0.51) ALDH1A1MAPTHSD17B10NPC1GFER
SCHEMBL21484904 0.78 ALDH1A1 (1.00) ALDH1A1MAPTHSD17B10NPC1GFER
SCHEMBL3418282 0.76 MAPT (0.63) ALDH1A1MAPTHSD17B10NPC1GFER
SCHEMBL18724213 0.74 ABL1 (0.53) ALDH1A1MAPTHSD17B10NPC1GFER
SCHEMBL17232442 0.74 ALDH1A1 (0.54) ALDH1A1MAPTHSD17B10NPC1GFER
SCHEMBL30723295 0.74 RAB9A (0.58) ALDH1A1MAPTHSD17B10NPC1KDM4E
SCHEMBL17221610 0.74 ALDH1A1 (0.51) ALDH1A1MAPTHSD17B10NPC1KDM4E
SCHEMBL10519613 0.73 ALDH1A1 (0.59) ALDH1A1MAPTHSD17B10NPC1GFER
SCHEMBL10519240 0.73 ALDH1A1 (0.54) ALDH1A1MAPTHSD17B10NPC1GFER
SCHEMBL10719025 0.72 ALDH1A1 (0.61) ALDH1A1MAPTHSD17B10NPC1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117486872-A Mechanical ball milling synthesis method of aminothiazole compound 浙江工业大学 2024-02-02 CN disclosed
EP-1283832-B1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2010-10-20 EP disclosed
US-7132436-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2006-11-07 US disclosed
US-20030166689-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 CLARIO TECH LIMITED (GB) 2003-09-04 US disclosed
CN-1437588-A 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors BIOVITRUM AB (SE) 2003-08-20 CN disclosed
EP-0321115-B1 CARBOXAMIDE DERIVATIVES HAVING TETRAZOLE AND THIAZOLE RINGS AND THEIR USE SAWAI PHARMACEUTICAL CO., LTD. (JP) 1991-08-14 EP disclosed
US-4946855-A ANTIALLERGIC SAWAI PHARMACEUTICAL CO., LTD. (JP) 1990-08-07 US disclosed
EP-0321115-A1 Carboxamide derivatives having tetrazole and thiazole rings and their use SAWAI PHARMACEUTICAL CO., LTD. (JP) 1989-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166689-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD11B2 ALDH1A1 55/4885MAPT 3275/4885HSD17B10 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.